Paolo Alessandroni

Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.

Giammaria Fiorentini, Camillo Aliberti, Massimo Tilli et al. · PubMed · 2012 · 331 citations

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

Giuseppe Perrone, Pier Adelchi Ruffini, Vincenzo Catalano et al. · European Journal of Cancer · 2008 · 208 citations

Gastrointestinal Oncology, Medicine, T-regulatory Cell +8

Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy

Vincenzo Catalano, Fotios Loupakis, Francesco Graziano et al. · British Journal of Cancer · 2009 · 191 citations · Full text

Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer

Vincenzo Catalano, Fotios Loupakis, Francesco Graziano et al. · Annals of Oncology · 2011 · 114 citations · Full text

Surgical Oncology, Stage Ii, Mucinous Histology +13

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.

Stefano Cascinu, Roberto Labianca, Paolo Alessandroni et al. · Journal of Clinical Oncology · 1997 · 103 citations